Profile
Richard Schoenfeld is Vice President of Operations for PharmAthene, Inc. He joined PharmAthene in October 2005.
He was Vice President of Supply Chain Management for EMD Pharmaceuticals and Senior Vice President of Engineering and Technology Development for Genzyme.
Mr. Schoenfeld held various positions at Endotronics and Monsanto.
He had 30 years of experience in developing and manufacturing proteins.
Mr. Schoenfeld received an Advanced Graduate Certificate in Business Ethics from Bentley College.
He received an MS and a PhD in Bioengineering from the Polytechnic Institute of Brooklyn, a BS in Chemical Engineering from Northeastern University and an MBA from St. Louis University.
Former positions of Richard Schoenfeld
| Companies | Position | End |
|---|---|---|
PharmAthene, Inc. /Old/
PharmAthene, Inc. /Old/ BiotechnologyHealth Technology Develops biotherapeutics to address biological pathogens and chemicals | Chief Operating Officer | 09/08/2007 |
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology Develops bio therapeutics to address biological pathogens and chemicals | Corporate Officer/Principal | - |
Training of Richard Schoenfeld
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
PharmAthene, Inc. /Old/
PharmAthene, Inc. /Old/ BiotechnologyHealth Technology Develops biotherapeutics to address biological pathogens and chemicals | Health Technology |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Polytechnic University
Polytechnic University Other Consumer ServicesConsumer Services College/University | Consumer Services |
St. Louis University
St. Louis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology Develops bio therapeutics to address biological pathogens and chemicals | Health Technology |
- Stock Market
- Insiders
- Richard Schoenfeld
















